Question from Deputy Roderic O'Gorman - PQ 38934-26
Deputy O'Gorman asked if the HSE is considering funding the use of 'focal therapy' for the treatment of prostate cancer. Read the HSE response.
- Published date:
- :
Browse and read HSE's latest publications, which include strategic plans, reports, official policies and codes, Parliamentary Question (PQ) responses, and board meeting minutes.
Deputy O'Gorman asked if the HSE is considering funding the use of 'focal therapy' for the treatment of prostate cancer. Read the HSE response.
Deputy O'Flynn asked about the total expenditure details of treatment abroad scheme cases since 2020. Read the HSE response.
Deputy O'Flynn asked if any centralised framework exists governing long-term outcome monitoring treatment abroad for minors. Read the HSE response.
Deputy O'Flynn asked whether any national framework exists governing audit of overseas referrals funded through TAS. Read the HSE response.
Deputy Burke asked about the supports available through the HSE QUIT smoking cessation service. Read the HSE response.
Deputy O'Flynn asked about the annual cost to the Exchequer of unused, expired, uncollected, or otherwise wasted medicines. Read the HSE response.
Deputy McGreehan asked about eligibility criteria for patients applying under the Treatment Abroad Scheme. Read the HSE response.
Deputy Sheehan asked about the scoping exercise regarding the preferred model for a dedicated Sexual Assault Treatment Unit (SATU) in the Midwest region.
Deputy O'Flynn asked about SCAN services in the HSE Mid West. Read the HSE response.
Deputy O'Flynn asked about the reimbursement assessment process for omaveloxolone (skyclarys). Read the HSE response.